Subcellular Localization of the bcl-2 Protein in Malignant and Normal Lymphoid Cells

Cancer Research

Volumn 54, Issue 1, 1994, Pages 256-260

  de Jong, Daphne ^a   Prins, Frans A ^a   Mason, David Y ^b   Reed, John C ^c   van Ommen, Gertjan B ^a   Kluin, Philip M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; BONE MARROW CELL; CANCER CELL; CELL MEMBRANE TRANSPORT; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHROMOSOME 18; CHROMOSOME TRANSLOCATION 14; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL LINE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

3,3'-DIAMINOBENZIDINE; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; HUMANS; INTRACELLULAR MEMBRANES; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; MITOCHONDRIA; NUCLEAR ENVELOPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSLOCATION, GENETIC;

EID: 0028157171     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Levine, E. G. Arthur, D. C. Frizzera, G. Peterson, B. A. Hurd, D. D., and Bloom-field, C. D. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood, 66: 1414–1414, 1985.
2. Yunis, J. J. Oken, M. M. Kaplan, M. E. Ensrud, K. M. Howe, R. R., and The-ologides, A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphomas. N. Engl. J. Med. 307: 1231–1236, 1982.
3. Tsujimoto, Y. Gorham, J. Cossman, J. Jaffe, E., and Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (Washington DC), 229: 1390–1393, 1985.
4. Graninger, W. Seto, M. Boutain, B. Goldman, P., and Korsmeyer, S. J. Expression of BCL-2 and BCL-2-Ig fusion transcripts in normal and neoplastic cells. J. Clin. Invest. 80: 1512–1515, 1987.
5. Reed, J. C. Tsujimoto, Y. Epstein, S. E. Cuddy, M. Slabiak, T. Nowell, P. C., and Croce, C. M. Regulation of bcl-2 gene expression in lymphoid cell lines containing normal # 18 or t(14;18) chromosomes. Oncogene Res. 4: 271–282, 1989.
6. Seto, M. Jaeger, U. Hockett, R. D. Graninger, W. Bennett, S. Goldman, P., and Korsmeyer, S. J. Alternative promoters and exons, somatic mutations and deregulation of the Bcl-2 Ig fusion gene in lymphoma. EMBO J. 7: 123–131, 1988.
7. Alnemri, E. S. Fernandes, T. F. Haldar, S. Croce, C. M., and Litwack, G. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res. 52: 491–495, 1992.
8. Borzillo, G. V. Endo, K., and Tsujimoto, Y. Bcl2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene, 7: 869–876, 1992.
9. Hockenbery, D. Nunez, G. Milliman, C. Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334–336, 1990.
10. Reed, J. C. Meister, L. Tanaka, S. Cuddy, M. Yum, S. Geyer, C., and Pleasure, D. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 51: 6529–6538, 1991.
11. Vaux, D. L. Cory, S., and Adams, J. M. Bcl-2 gene promotes haemapoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440–442, 1988.
12. Sentman, C. L. Shutter, J. R. Hockenbery, D. Kanagawa, O., and Korsmeyer, S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67: 879–888, 1991.
13. Strasser, A. Harris, A. W., and Cory, S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67: 889–899, 1991.
14. McDonnell, T. J. Deane, N. Platt, F. M. Nunez, G. Jaeger, U. McKearn, J. P., and Korsmeyer, S. J. 6c/-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57: 79–88, 1989.
15. McDonnell, T. J. Nunez, G. Piatt, F. M. Hockenberry, D. London, L. McKearn, J. P., and Korsmeyer, S. J. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol. 10: 1901–1907, 1990.
16. Strasser, A. Whittingham, S. Vaux, D. L. Bath, M. L. Adams, J. M. Cory, S., and Harris, A. W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA, 88: 8661–8665, 1991.
17. McDonnell, T J., and Korsmeyer, S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature (Lond.), 349: 254–256, 1991.
18. Strasser, A. Harris, A. W., and Cory, S. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T-cells. Oncogene, 8: 1–9, 1993.
19. Liu, Y-J. Mason, D. Y. Johnson, G. D. Abbot, S. Gregory, C. D. Hardie, D. L. Gordon, J., and MacLennan, I. C. M. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21: 1905–1910, 1991.
20. Nuñez, G. Hockenbery, D. McDonnell, T J. Sorensen, C. M., and Korsmeyer, S. J. Bcl-2 maintains B cell memory. Nature (Lond.), 353: 71–73, 1991.
21. Cleary, M. L. Smith, S. D., and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19–28, 1986.
22. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts, and protein products of BCL-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214–5218, 1986.
23. Chen-Levy, Z. Nourse, J., and Cleary, M. L. The BCL-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell. Biol. 9: 701–710, 1989.
24. Chen-Levy, Z., and Cleary, M. L. Membrane topology of the bcl-2 proto-oncogenic protein demonstrated in vitro. J. Biol. Chem. 265: 4929–4933, 1990.
25. Tsujimoto, Y. Ikegaki, N., and Croce, C. M. Characterization of the protein product of BCL-2, the gene involved in human follicular lymphoma. Oncogene, 2: 3–7, 1987.
26. Boise, L. H. Gonzales-Garcia, M. Postema, C. E. Ding, L. Lindsten, T. Turka, L. A. Mao, X. Nunez, G., and Thompson, C. B. Bcl-x, a bcl-2-related gene that functions as dominant regulator of apoptotic cell death. Cell, 74: 597–608, 1993.
27. Kozopas, K. M. Yang, T. Buchan, H. L. Zhou, P., and Craig, R. W. MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc. Natl. Acad. Sci. USA, 90: 3516–3520, 1993.
28. Oltvai, Z. N. Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609–619, 1993.
29. Kluin-Nelemans, J. C. Limpens, J. Meerabux, J. Beverstock, G. C. Jansen, J. H. De Jong, D., and Kluin, P. M. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21). Leukemia (Baltimore), 5: 221–224, 1991.
30. Cornelese-ten Velde, I., and Prins, F. New sensitive light microscopical detection of colloidal gold on ultra-thin sections by reflection contrast microscopy. Combination of reflection contrast and electron microscopy in post embedding immunogold histochemistry. Histochemistry, 94: 61–71, 1990.
31. Geuze, H. J. Slot, J. W. Ley van der, P. A., and Scheffer, R. C. Use of colloidal gold particles in double-labelling immunoelectron microscopy of ultrathin frozen tissue sections. J. Cell Biol. 38: 87–93, 1981.
32. Griffiths, G. McDowall, A. Back, R., and Dubochet, J. On the preparation of cryosections of immunocytochemistry. J. Ultrastruct. Res. 89: 65–78, 1984.
33. Prezzella, F. Tse, A. G. D. Cordell, J. L. Pulford, K. A. R. Gatter, K. C., and Mason, D. Y Expression of the bcl-2 oncogene protein is not specific for the t(14;18) chromosomal translocation. Am. J. Pathol. 137: 225–232, 1990.
34. Reed, J. C. Tanaka, S. Cuddy, M. Cho, D. Smith, J. Kallen, R. Uri Saragovi, H., and Torigoe, T. A strategy for generating monoclonal antibodies against recombinant baculovirus-produced proteins: application to the Bcl-2 oncoprotein. Anal. Biochem. 205: 70–76, 1992.
35. Delia, D. Aiello, A. Soligo, D. Fontanella, E. Melani, C. Pezzella, R. Pierotti, M. A., and Delia Porta, G. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood, 79: 1291–1298, 1992.
36. Monaghan, P. Robertson, D. Amos, T. A. S. Dyer, M. J. S. Mason, D. Y., and Greaves, M. F. Ultrastructural localization of BCL-2 protein. J. Histochem. Cyto-chem. 40: 1819–1825, 1992.
37. Pain, D. Kanwar, Y., and Blobel, G. Identification of a receptor for protein import into chloroplast and its localization to envelop contact zones. Nature (Lond.), 331: 232–237, 1988.
38. Pfanner, N. Sollner, T., and Neupert, W. Mitochondrial import receptors for precursor proteins. Trends Biochem. Sci. 16: 63–67, 1991.
39. Schleyer, T., and Neupert, W. Transport of proteins into mitochondria: translocation intermediates spanning contact sites between outer and inner membranes. Cell, 43: 339–350, 1985.
40. Schwaiger, M. Herzog, V., and Neupert, W. Characterization of translocation contact sites involved in the import of mitochondrial proteins. Cell. Biol. 105: 235–246, 1987.
41. Jacobson, M. D. Burne, J. F. King, M. P. Miyashita, T. Reed, J. C., and Raff, M. C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 361: 365–369, 1993.
42. Goldfarb, D. S. Are the cytosolic components of the nuclear, ER and mitochondrial import apparatus functionally related? Cell, 70: 185–188, 1992.
43. Hawlitschek, G. Schneider, H. Schmidt, B. Tropschug, M. Hartl, F. U., and Neupert, W. Mitochondrial protein import: identification of processing peptidase and of PEP, a processing enhancing protein. Cell, 53: 795–800, 1988.
44. Murakami, H. Blobel, G., and Pain, D. Isolation and characterization of the gene for a yeast import receptor. Nature (Lond.), 347: 488–491, 1990.
45. Haffy, G. Miyawaki, T. Williamson, J. R., and Reed, J. C. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an U-3-dependent hemopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J. Biol. Chem. in press, 1993.
46. 2+ concentrations. Arch. Biochem. Biophys. 269: 365–370, 1989.
47. Mechanisms in B-cell neoplasia. Proceeding of workshop. Curr. Top. Microbiol. Immunol. 182: 287–292, 1992.